Follow-up of the VIPES Study to Evaluate Efficacy and Safety of Viaskin Peanut in Adults and Children
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Peanut Allergy
Related studies linked through entity extraction aliases.
The Utility of Food-Specific IgE Measured With the IMMULITE 2000 Assay to Predict Symptomatic Food Allergy
- Status
- COMPLETED
- Phase
- N/A
Walnut Oral Immunotherapy for Tree Nut Allergy
- Status
- WITHDRAWN
- Phase
- NA
The Safety and Efficacy of a Peanut Immunotherapy Dissolving Film for Peanut Allergy
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Canadian Peanut Thresholds Study
- Status
- UNKNOWN
- Phase
- NA
Peanut Reactivity Reduced by Oral Tolerance in an Anti-IgE Clinical Trial
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Tolerance Following Peanut Oral Immunotherapy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy
- Status
- COMPLETED
- Phase
- PHASE2
Peanut Allergy Oral Immunotherapy Desensitization
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of Allergenicity of Hypoallergenic Peanut Product in Peanut Allergic Subjects
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety of 4 Doses of QGE031 in Patients 18-50 Years of Age With Peanut Allergy
- Status
- WITHDRAWN
- Phase
- PHASE2
Sublingual Immunotherapy for Peanut Allergy and Induction of Tolerance
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Oral Peanut Immunotherapy
- Status
- COMPLETED
- Phase
- NA
Xolair Enhances Oral Desensitization in Peanut Allergic Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Peanut Oral Immunotherapy (OIT) - Initial Pilot Study in Adults
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of Tolerance to Oral Peanut
- Status
- COMPLETED
- Phase
- PHASE1
Epicutaneous Immunotherapy in Peanut Allergy in Children
- Status
- COMPLETED
- Phase
- PHASE2
Safety of Epicutaneous Immunotherapy for the Treatment of Peanut Allergy
- Status
- COMPLETED
- Phase
- PHASE1
Understanding How the Immune System Responds to Viruses in Peanut Allergic Children Undergoing Peanut Oral Immunotherapy
- Status
- COMPLETED
- Phase
- NA
Omalizumab in the Treatment of Peanut Allergy
- Status
- COMPLETED
- Phase
- PHASE2